GB0608655D0 - Therapeutic Treatment - Google Patents
Therapeutic TreatmentInfo
- Publication number
- GB0608655D0 GB0608655D0 GBGB0608655.7A GB0608655A GB0608655D0 GB 0608655 D0 GB0608655 D0 GB 0608655D0 GB 0608655 A GB0608655 A GB 0608655A GB 0608655 D0 GB0608655 D0 GB 0608655D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic treatment
- therapeutic
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0608655.7A GB0608655D0 (en) | 2006-05-03 | 2006-05-03 | Therapeutic Treatment |
PCT/GB2007/050224 WO2007129111A1 (en) | 2006-05-03 | 2007-04-30 | Diazepine derivatives as 5-ht2a antagonists |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0608655.7A GB0608655D0 (en) | 2006-05-03 | 2006-05-03 | Therapeutic Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0608655D0 true GB0608655D0 (en) | 2006-06-14 |
Family
ID=36603774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0608655.7A Ceased GB0608655D0 (en) | 2006-05-03 | 2006-05-03 | Therapeutic Treatment |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0608655D0 (en) |
WO (1) | WO2007129111A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS20060035A (en) | 2003-07-22 | 2008-08-07 | Arena Pharmaceuticals Inc., | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
SA05260357B1 (en) | 2004-11-19 | 2008-09-08 | ارينا فارماسيتو تيكالز ، أنك | 3-phenyle-pyrazole derivatives as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto |
ES2536762T3 (en) | 2006-05-18 | 2015-05-28 | Arena Pharmaceuticals, Inc. | Primary amines and their derivatives as 5-HT2A serotonin receptor modulators useful for the treatment of disorders related to this |
NZ571829A (en) | 2006-05-18 | 2011-10-28 | Arena Pharm Inc | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor |
CN104761498B (en) | 2006-05-18 | 2017-12-26 | 艾尼纳制药公司 | The conditioning agent of 5 HT2A serotonin receptors |
TWI415845B (en) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
JP5393677B2 (en) | 2007-08-15 | 2014-01-22 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Imidazo [1,2-a] pyridine derivatives as modulators of 5-HT2A serotonin receptors for the treatment of disorders associated with 5-HT2A serotonin receptors |
NZ594937A (en) * | 2008-02-19 | 2013-03-28 | Adolor Corp | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
RS57110B1 (en) | 2008-10-28 | 2018-06-29 | Arena Pharm Inc | Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
WO2011075596A1 (en) | 2009-12-18 | 2011-06-23 | Arena Pharmaceuticals, Inc. | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
CN109562085A (en) | 2015-06-12 | 2019-04-02 | 阿速万科学有限责任公司 | For preventing and treating the diaryl and aryl heteroaryl urea derivative of REM sleep behavior disorder |
AU2016291673A1 (en) | 2015-07-15 | 2018-01-25 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4315860A (en) * | 1974-03-29 | 1982-02-16 | Sandoz, Inc. | 5-Pyrrolidino, piperidino or N'-2-hydroxyethylpiperazino-7-phenyl or substituted phenyl-2,3-dihydro-1H-1,4-diazepines |
CH613696A5 (en) * | 1974-03-29 | 1979-10-15 | Sandoz Ag | Process for the preparation of novel 5-amino-7-phenyl-2,3-dihydro-1H-1,4-diazepines |
AT355025B (en) * | 1974-11-29 | 1980-02-11 | Sandoz Ag | METHOD FOR PRODUCING NEW 5-AMINO-7-PHENYL-2,3-DIHYDRO-1H-1,4-DIAZEPINE |
-
2006
- 2006-05-03 GB GBGB0608655.7A patent/GB0608655D0/en not_active Ceased
-
2007
- 2007-04-30 WO PCT/GB2007/050224 patent/WO2007129111A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007129111A1 (en) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0602178D0 (en) | Therapeutic treatment | |
EP1982660A4 (en) | Treatment endoscope | |
IL198663A0 (en) | Tissue treatment methods | |
IL196559A0 (en) | Combination therapy | |
GB0609492D0 (en) | Therapeutic agents | |
GB0608928D0 (en) | Therapeutic agents | |
GB0608655D0 (en) | Therapeutic Treatment | |
GB0624874D0 (en) | Treatment | |
GB0601962D0 (en) | Therapeutic agents | |
GB0600692D0 (en) | Well treatment | |
IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
GB0616214D0 (en) | Therapeutic Agents | |
IL196556A0 (en) | Combination therapy | |
EP2054061A4 (en) | Combination therapy | |
GB0611152D0 (en) | Therapeutic agents | |
GB0620818D0 (en) | Therapeutic agents | |
GB0610909D0 (en) | Therapeutic treatment | |
GB0620059D0 (en) | Therapeutic agents | |
ZA200902203B (en) | Combination therapy | |
GB0607952D0 (en) | Novel treatment | |
GB0609676D0 (en) | Therapeutic agents | |
GB0604460D0 (en) | Treatment | |
GB0622195D0 (en) | Therapeutic agents | |
GB0606660D0 (en) | Targeted Therapy | |
GB0610376D0 (en) | Therapeutic treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |